ArticleCancers2024
Enhanced WGAN Model for Diagnosing Laryngeal Carcinoma.
Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development of AI-Based Laryngeal Cancer Diagnostic Platform Using Laryngoscope Images.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study modifies the U-Net architecture for pixel-based segmentation to automatically classify lesions in laryngeal endoscopic images. The advanced U-Net incorporates five-level encoders and decoders, with an autoencoder layer to derive latent vectors representing the image characteristics. To enhance performance, a WGAN was implemented to address common issues such as mode collapse and gradient explosion found in traditional GANs. The dataset consisted of 8171 images labeled with polygons in seven colors. Evaluation metrics, including the F1 score and intersection over union, revealed that benign tumors were detected with lower accuracy compared to other lesions, while cancers achieved notably high accuracy. The model demonstrated an overall accuracy rate of 99%. This enhanced U-Net model shows strong potential in improving cancer detection, reducing diagnostic errors, and enhancing early diagnosis in medical applications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.